Oxidation of β2-glycoprotein I associates with IgG antibodies to domain I in patients with antiphospholipid syndrome.

Domain I (DI) of beta-2-glycoprotein I (β2GPI) contains the immunodominant epitope for pathogenic antiphospholipid antibodies (aPL). DI is exposed in the linear form of the molecule but not in the circular form that comprises 90% of serum β2GPI. The majority of circulating β2GPI is biochemically red...

Full description

Bibliographic Details
Main Authors: Maria Gabriella Raimondo, Charis Pericleous, Anna Radziszewska, Maria Orietta Borghi, Silvia Pierangeli, Pier Luigi Meroni, Ian Giles, Anisur Rahman, Yiannis Ioannou
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2017-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0186513
id doaj-8e2b63c007d34c27b62428d71f05b970
record_format Article
spelling doaj-8e2b63c007d34c27b62428d71f05b9702021-03-04T12:41:02ZengPublic Library of Science (PLoS)PLoS ONE1932-62032017-01-011210e018651310.1371/journal.pone.0186513Oxidation of β2-glycoprotein I associates with IgG antibodies to domain I in patients with antiphospholipid syndrome.Maria Gabriella RaimondoCharis PericleousAnna RadziszewskaMaria Orietta BorghiSilvia PierangeliPier Luigi MeroniIan GilesAnisur RahmanYiannis IoannouDomain I (DI) of beta-2-glycoprotein I (β2GPI) contains the immunodominant epitope for pathogenic antiphospholipid antibodies (aPL). DI is exposed in the linear form of the molecule but not in the circular form that comprises 90% of serum β2GPI. The majority of circulating β2GPI is biochemically reduced with two free thiols in Domain V. However, increased levels of oxidised β2GPI are found in patients with antiphospholipid syndrome (APS). It is not known whether oxidation of β2GPI favours the linear form of the molecule and thus promotes development of anti-DI antibodies. We investigated whether the proportion of oxidised β2GPI associates with the presence of anti-DI in APS patients. Serum samples from 44 APS patients were screened for IgG, IgM and IgA anti-DI, anti-β2GPI, anti-cardiolipin (anti-CL) and biochemically reduced β2GPI. A negative correlation was found between the proportion of β2GPI in the biochemically reduced form and IgG anti-DI levels (r = -0.54, p = 0.0002), but not with IgM or IgA anti-DI. Moreover, the proportion of β2GPI in the reduced form was lower in IgG anti-DI positive than anti-DI negative APS patients (p = 0.02). The relative amount of reduced β2GPI was no different between patients who were positive or negative for IgG, IgM and IgA anti-β2GPI or anti-CL. This study demonstrates that oxidised β2GPI lacking free cysteine-thiol groups most closely associates with IgG anti-DI positivity compared to IgG anti-CL and anti-β2GPI. Future studies are required to ascertain the directionality of this association to define causation.https://doi.org/10.1371/journal.pone.0186513
collection DOAJ
language English
format Article
sources DOAJ
author Maria Gabriella Raimondo
Charis Pericleous
Anna Radziszewska
Maria Orietta Borghi
Silvia Pierangeli
Pier Luigi Meroni
Ian Giles
Anisur Rahman
Yiannis Ioannou
spellingShingle Maria Gabriella Raimondo
Charis Pericleous
Anna Radziszewska
Maria Orietta Borghi
Silvia Pierangeli
Pier Luigi Meroni
Ian Giles
Anisur Rahman
Yiannis Ioannou
Oxidation of β2-glycoprotein I associates with IgG antibodies to domain I in patients with antiphospholipid syndrome.
PLoS ONE
author_facet Maria Gabriella Raimondo
Charis Pericleous
Anna Radziszewska
Maria Orietta Borghi
Silvia Pierangeli
Pier Luigi Meroni
Ian Giles
Anisur Rahman
Yiannis Ioannou
author_sort Maria Gabriella Raimondo
title Oxidation of β2-glycoprotein I associates with IgG antibodies to domain I in patients with antiphospholipid syndrome.
title_short Oxidation of β2-glycoprotein I associates with IgG antibodies to domain I in patients with antiphospholipid syndrome.
title_full Oxidation of β2-glycoprotein I associates with IgG antibodies to domain I in patients with antiphospholipid syndrome.
title_fullStr Oxidation of β2-glycoprotein I associates with IgG antibodies to domain I in patients with antiphospholipid syndrome.
title_full_unstemmed Oxidation of β2-glycoprotein I associates with IgG antibodies to domain I in patients with antiphospholipid syndrome.
title_sort oxidation of β2-glycoprotein i associates with igg antibodies to domain i in patients with antiphospholipid syndrome.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2017-01-01
description Domain I (DI) of beta-2-glycoprotein I (β2GPI) contains the immunodominant epitope for pathogenic antiphospholipid antibodies (aPL). DI is exposed in the linear form of the molecule but not in the circular form that comprises 90% of serum β2GPI. The majority of circulating β2GPI is biochemically reduced with two free thiols in Domain V. However, increased levels of oxidised β2GPI are found in patients with antiphospholipid syndrome (APS). It is not known whether oxidation of β2GPI favours the linear form of the molecule and thus promotes development of anti-DI antibodies. We investigated whether the proportion of oxidised β2GPI associates with the presence of anti-DI in APS patients. Serum samples from 44 APS patients were screened for IgG, IgM and IgA anti-DI, anti-β2GPI, anti-cardiolipin (anti-CL) and biochemically reduced β2GPI. A negative correlation was found between the proportion of β2GPI in the biochemically reduced form and IgG anti-DI levels (r = -0.54, p = 0.0002), but not with IgM or IgA anti-DI. Moreover, the proportion of β2GPI in the reduced form was lower in IgG anti-DI positive than anti-DI negative APS patients (p = 0.02). The relative amount of reduced β2GPI was no different between patients who were positive or negative for IgG, IgM and IgA anti-β2GPI or anti-CL. This study demonstrates that oxidised β2GPI lacking free cysteine-thiol groups most closely associates with IgG anti-DI positivity compared to IgG anti-CL and anti-β2GPI. Future studies are required to ascertain the directionality of this association to define causation.
url https://doi.org/10.1371/journal.pone.0186513
work_keys_str_mv AT mariagabriellaraimondo oxidationofb2glycoproteiniassociateswithiggantibodiestodomainiinpatientswithantiphospholipidsyndrome
AT charispericleous oxidationofb2glycoproteiniassociateswithiggantibodiestodomainiinpatientswithantiphospholipidsyndrome
AT annaradziszewska oxidationofb2glycoproteiniassociateswithiggantibodiestodomainiinpatientswithantiphospholipidsyndrome
AT mariaoriettaborghi oxidationofb2glycoproteiniassociateswithiggantibodiestodomainiinpatientswithantiphospholipidsyndrome
AT silviapierangeli oxidationofb2glycoproteiniassociateswithiggantibodiestodomainiinpatientswithantiphospholipidsyndrome
AT pierluigimeroni oxidationofb2glycoproteiniassociateswithiggantibodiestodomainiinpatientswithantiphospholipidsyndrome
AT iangiles oxidationofb2glycoproteiniassociateswithiggantibodiestodomainiinpatientswithantiphospholipidsyndrome
AT anisurrahman oxidationofb2glycoproteiniassociateswithiggantibodiestodomainiinpatientswithantiphospholipidsyndrome
AT yiannisioannou oxidationofb2glycoproteiniassociateswithiggantibodiestodomainiinpatientswithantiphospholipidsyndrome
_version_ 1714801919888719872